SynthesisJournal of gastrointestinal cancer2026

A Meta-Analysis on Outcomes of Zanidatamab Plus Chemotherapy in Patients with Advanced HER2-positive Gastroesophageal Adenocarcinoma.

Henrique Jin Son Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.